Mazen Animal Health is an Iowa-based startup developing oral alternatives to injectable vaccines for pigs and poultry using plants—particularly corn—as molecular farms to produce vaccine proteins. Administering vaccines in feed reduces worker exposure and labor compared with injecting animals. The company says its plant-based production is cheaper than precision fermentation in bioreactors and traditional vaccine methods. Mazen has made progress on a lead oral vaccine for Porcine Epidemic Diarrhea Virus (PEDV) and is conducting USDA-required efficacy studies. The Series A financing will be used to scale commercial manufacturing capacity and to advance a pipeline of other vaccines, including one for coccidiosis in poultry.

Total raised

$11M

Funding rounds

1

Latest round

Series A

Latest activity

May 2022